Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study to Evaluate the Equivalence of Estradiol Vaginal Cream to Reference Standard in the Treatment of Vaginal Atrophy

ClinicalTrials.gov ID: NCT03332303

Public ClinicalTrials.gov record NCT03332303. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:01 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Multi-Site Study to Evaluate Therapeutic Equivalence of Estradiol Vaginal Cream, USP, 0.01% (Prasco LLC) to Estrace® Cream (Warner Chilcott) in Treatment of Vulvar and Vaginal Atrophy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objectives of this study are to evaluate the therapeutic equivalence of the Test formulation, Estradiol Vaginal Cream 0.01% (Prasco, LLC) to the marketed product, Estrace® Cream (estradiol vaginal cream, 0.01%) in patients with vulvar and vaginal atrophy, and compare the safety of Test, Reference and Placebo treatments in patients with vulvar and vaginal atrophy.

Study identification

NCT ID
NCT03332303
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Prasco LLC
Industry
Enrollment
540 participants

Conditions and interventions

Eligibility (public fields only)

Age range
30 Years to 75 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 26, 2017 (Actual)
Primary completion
Mar 15, 2018 (Actual)
Completion
Mar 15, 2018 (Actual)
Last update posted
May 30, 2024

2017 – 2018

United States locations

U.S. sites
27
U.S. states
13
U.S. cities
26
Facility City State ZIP Site status
Douglas Young, MD Sacramento California 95821 —
Medical Center for Clinical Research San Diego California 92108 —
Women's Health Care Research Corp. San Diego California 92111 —
Downtown Women's Health Care Denver Colorado 80209 —
Avail Clinical Research, LLC DeLand Florida 32720 —
Health Awareness, Inc. Jupiter Florida 33458 —
New Age Medical Research Corporation Miami Florida 33186 —
Panax Clinical Research Miami Lakes Florida 33014 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Ormond Medical Arts Pharmaceutical Research Center Ormond Beach Florida 32174 —
Health Awareness, Inc. Port Saint Lucie Florida 34952 —
Physician Care Clinical Research, LLC Sarasota Florida 34239 —
Well Pharma Medical Research Group South Miami Florida 33143 —
Meridien Research, Inc. St. Petersburg Florida 33709 —
Comprehensive Clinical Trials, LLC West Palm Beach Florida 33409 —
Cypress Medical Research Center, LLC Wichita Kansas 67226 —
Praetorian Pharmaceutical Marrero Louisiana 70072 —
Southern Clinical Research Associates Metairie Louisiana 70001 —
Canton Obstetrics and Gynecology Canton Michigan 48187 —
Beyer Research Kalamazoo Michigan 49009 —
Women's Clinic of Lincoln Lincoln Nebraska 68510 —
Lawrence Ob-Gyn Clinical Research, LLC Lawrenceville New Jersey 08648 —
Aventiv Research, Inc. Columbus Ohio 43213 —
Novum PRS Pittsburgh Pennsylvania 15219 —
Coastal Carolina Research Center Mt. Pleasant South Carolina 29464 —
Vernon & Waldrep OBGYN Associates Dallas Texas 75230 —
Women's Clinical Research Center dba Seattle Women's Health, Research, Gynecology Seattle Washington 98105 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03332303, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 30, 2024 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03332303 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →